1. I. Ilic and M. Ilic, '"International patterns and trends in the brain cancer incidence and mortality: an observational study based on the global burden of disease," Heliyon, vol. 9, no. 7, Jul 01, pp. e18222.
2. M. Adewole, J.D. Rudie, A. Gbdamosi, O. Toyobo, C. Raymond, D. Zhang, O. Omidiji, R. Akinola, M.A. Suwaid, A. Emegoakor, N. Ojo, K. Aguh, C. Kalaiwo, G. Babatunde, A. Ogunleye, Y. Gbadamosi, K. Iorpagher, E. Calabrese, M. Aboian, M. Linguraru, J. Albrecht, B. Wiestler, F. Kofler, A. Janas, D. LaBella, A.F. Kzerooni, H.B. Li, J.E. Iglesias, K. Farahani, J. Eddy, T. Bergquist, V. Chung, R.T. Shinohara, W. Wiggins, Z. Reitman, C. Wang, X. Liu, Z. Jiang, A. Familiar, K. Van Leemput, C. Bukas, M. Piraud, G. Conte, E. Johansson, Z. Meier, B.H. Menze, U. Baid, S. Bakas, F. Dako, A. Fatade and U.C. Anazodo, '"The brain tumor segmentation (BraTS) challenge 2023: glioma segmentation in sub-saharan africa patient population (BraTS-Africa)," ArXiv, May 30, pp. arXiv:2305.19369v1 (82-64).
3. Brain cancer diagnosis and therapy with nanoplatforms;Koo;Adv. Drug Deliv. Rev.,2006
4. Targeted drug delivery for brain cancer treatment;Gutman;J. Contr. Release,2000
5. The blood–brain barrier: an overview: structure, regulation, and clinical implications;Ballabh;Neurobiol. Dis.,2004